Immunosuppression and outcomes of patients transplanted for hepatitis C

J Hepatol. 2006 Apr;44(4):627-9. doi: 10.1016/j.jhep.2006.02.002. Epub 2006 Feb 17.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Adrenal Cortex Hormones / administration & dosage
  • Cyclosporine / therapeutic use
  • Hepacivirus / genetics
  • Hepacivirus / immunology
  • Hepatitis C / drug therapy*
  • Hepatitis C / surgery*
  • Humans
  • Immunosuppression Therapy / methods*
  • Immunosuppressive Agents / administration & dosage*
  • Immunosuppressive Agents / immunology
  • Liver / chemistry
  • Liver / pathology
  • Liver / virology
  • Liver Transplantation / immunology*
  • Muromonab-CD3 / therapeutic use
  • Mycophenolic Acid / analogs & derivatives
  • Mycophenolic Acid / therapeutic use
  • RNA, Messenger / analysis
  • RNA, Viral / analysis
  • Recurrence
  • Tacrolimus / therapeutic use
  • Treatment Outcome

Substances

  • Adrenal Cortex Hormones
  • Immunosuppressive Agents
  • Muromonab-CD3
  • RNA, Messenger
  • RNA, Viral
  • Cyclosporine
  • Mycophenolic Acid
  • Tacrolimus